Vitamin D and Tobacco Use and Long-Term Clinical and MRI Outcomes among CIS patients: 11-year Follow-up of BENEFIT. (P5.2-003)
Elena H. Martínez‐Lapiscina(Hospital Clínic de Barcelona), Alberto Ascherio(Brigham and Women's Hospital), Bernhard Hemmer(TUM Klinikum), Edward Fox(Penn State Milton S. Hershey Medical Center), Marianna Cortese(Harvard University), Xavier Montalbán(Universitat de Vic - Universitat Central de Catalunya), Iris‐Katharina Penner(University of Bern), Frederick W. Foley(Albert Einstein College of Medicine), Eva‐Maria Wicklein(Consorci Institut D'Investigacions Biomediques August Pi I Sunyer), Ludwig Kappos(Novartis (Switzerland)), Hans‐Peter Hartung(The University of Sydney), Frederik Barkhof(Netherlands Institute for Neuroscience), Sven Schippling(University Hospital of Zurich), Gilles Edan(Centre National de la Recherche Scientifique), Kassandra L. Munger(Harvard University), Mark S. Freedman(University of Ottawa)
Cited by 0
Related Papers
Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria
|Annals of Neurology|2011|9.8k
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
|The Lancet Neurology|2017|8k
Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis
|Annals of Neurology|2001|7k
Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration
|The Lancet Neurology|2013|5.4k
Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”
|Annals of Neurology|2005|5k